Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Average Rating of “Hold” by Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has been given a consensus recommendation of “Hold” by the eight analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, one has given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $5,400.00.

RBGLY has been the subject of a number of analyst reports. UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. JPMorgan Chase & Co. downgraded Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th.

Read Our Latest Report on RBGLY

Reckitt Benckiser Group Price Performance

RBGLY stock opened at $12.08 on Monday. The firm has a fifty day moving average price of $11.38 and a 200 day moving average price of $11.32. Reckitt Benckiser Group has a fifty-two week low of $10.24 and a fifty-two week high of $15.03.

Reckitt Benckiser Group Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Monday, September 23rd. Investors of record on Monday, August 5th will be issued a $0.1915 dividend. The ex-dividend date of this dividend is Monday, August 5th.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.